Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
NCT00664222 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2008-04-22
Summary
The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.
Conditions
- Chronic Stable Heart Failure
Interventions
- DRUG
-
spironolactone + furosemide
spironolactone 25mg/day, 16 weeks and furosemide 20mg/day, 16weeks
Sponsors & Collaborators
-
Tottori University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2005-12-31
More Related Trials
-
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
NCT00094302 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS
NCT00652652 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Ultra High Dose Diuretics to Treat Heart Failure
NCT06036914 ·Status: COMPLETED ·Phase: PHASE2
-
Aldosterone Blockade in Heart Failure
NCT00523757 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA
-
Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
NCT01406015 ·Status: COMPLETED ·Phase: NA
-
Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study
NCT04465123 ·Status: UNKNOWN ·Phase: PHASE3
-
Spironolactone in Patients With Single Ventricle Heart
NCT00211081 ·Status: COMPLETED ·Phase: NA
-
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
NCT02546583 ·Status: COMPLETED ·Phase: PHASE1
-
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
NCT07263035 ·Status: RECRUITING ·Phase: PHASE4
-
Spironolactone in the Treatment of Heart Failure
NCT04727073 ·Status: TERMINATED ·Phase: PHASE3
-
Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction
NCT04919564 ·Status: COMPLETED ·Phase: PHASE2
-
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
NCT00403910 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
NCT01028170 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253 ·Status: COMPLETED ·Phase: PHASE4
-
Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
NCT00335413 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Decreasing the Lasix Dose on the Cardiorenal System
NCT00982423 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
NCT02352285 ·Status: TERMINATED ·Phase: PHASE4
-
Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure
NCT04618601 ·Status: UNKNOWN ·Phase: PHASE4
-
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
NCT00306696 ·Status: COMPLETED ·Phase: PHASE4
-
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
NCT02235077 ·Status: COMPLETED ·Phase: PHASE2
-
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
NCT00291720 ·Status: COMPLETED ·Phase: PHASE2
-
Protocolized Diuretic Strategy in Cardiorenal Failure
NCT01921829 ·Status: TERMINATED ·Phase: PHASE4
-
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
NCT00125437 ·Status: TERMINATED ·Phase: NA
-
Spironolactone in Adult Congenital Heart Disease
NCT01069510 ·Status: COMPLETED ·Phase: PHASE2